Eyenovia, Inc. (EYEN)

Eyenovia Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.01	0	0	14	2	0
Revenue Growth (YoY)	-	-	-	600.00%	-	-
Cost of Revenue	-0.01	-0	0	1.6	0.8	0
Gross Profit	0.02	0.01	0	12.4	1.2	0
Selling, General & Admin	13.33	12.43	13.53	10.57	7.63	7.21
Research & Development	14.89	12.98	13.38	14.85	13.36	14.1
Other Operating Expenses	2	0	0	0	0	0
Operating Expenses	30.21	25.41	26.91	25.42	20.99	21.31
Operating Income	-30.2	-25.4	-26.91	-13.02	-19.79	-21.31
Interest Expense / Income	2.6	2.37	1.38	0.39	0.02	0
Other Expense / Income	-0.35	-0.51	-0.28	-0.63	-0.04	-0.15
Pretax Income	-32.44	-27.26	-28.01	-12.78	-19.77	-21.16
Net Income	-32.44	-27.26	-28.01	-12.78	-19.77	-21.16
Shares Outstanding (Basic)	47	41	34	26	21	14
Shares Outstanding (Diluted)	47	41	34	26	21	14
Shares Change	24.58%	21.94%	27.83%	25.03%	46.73%	51.42%
EPS (Basic)	-0.73	-0.66	-0.83	-0.49	-0.94	-1.47
EPS (Diluted)	-0.73	-0.66	-0.83	-0.49	-0.94	-1.47
Free Cash Flow	-30.02	-27.81	-25.98	-22.49	-6.65	-19.09
Free Cash Flow Per Share	-0.64	-0.68	-0.77	-0.85	-0.32	-1.33
Gross Margin	200.00%	200.00%	-	88.57%	60.00%	-
Operating Margin	-343927.95%	-670685.82%	-	-93.00%	-989.46%	-
Profit Margin	-369519.72%	-719859.94%	-	-91.27%	-988.49%	-
Free Cash Flow Margin	-341869.79%	-734277.16%	-	-160.66%	-332.28%	-
EBITDA	-29.01	-24.11	-26.32	-12.17	-19.66	-21.14
EBITDA Margin	-330448.92%	-636547.06%	-	-86.92%	-982.87%	-
Depreciation & Amortization	0.83	0.78	0.31	0.22	0.1	0.02
EBIT	-29.85	-24.89	-26.63	-12.39	-19.75	-21.16
EBIT Margin	-339946.75%	-657228.55%	-	-88.50%	-987.64%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).